LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 30.90 | 27.76 | 2300 | 2032 | 1.1317 | 1.0403 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 32.60 | 27.76 | 2050 | 2235 | 0.9169 | 0.9728 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 32.60 | 27.76 | 2096 | 2235 | 0.9375 | 0.9797 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 32.60 | 27.76 | 554 | 2235 | 0.2478 | 0.6045 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 32.60 | 27.76 | 2364 | 2235 | 1.0573 | 1.0177 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 34.30 | 27.76 | 2199 | 2449 | 0.8976 | 0.9669 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 34.30 | 27.76 | 2243 | 2449 | 0.9156 | 0.9729 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 34.30 | 27.76 | 634 | 2449 | 0.2588 | 0.6226 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 34.30 | 27.76 | 2618 | 2449 | 1.0687 | 1.0207 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 36.01 | 27.76 | 2349 | 2662 | 0.8821 | 0.9623 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 36.01 | 27.76 | 2380 | 2662 | 0.8938 | 0.9662 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 36.01 | 27.76 | 708 | 2662 | 0.2659 | 0.6355 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 36.01 | 27.76 | 2765 | 2662 | 1.0383 | 1.0115 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 37.71 | 27.76 | 2529 | 2877 | 0.8788 | 0.9618 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 37.71 | 27.76 | 2564 | 2877 | 0.8910 | 0.9658 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 37.71 | 27.76 | 804 | 2877 | 0.2794 | 0.6532 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 37.71 | 27.76 | 2980 | 2877 | 1.0356 | 1.0105 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 39.41 | 27.76 | 2645 | 3105 | 0.8517 | 0.9534 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 39.41 | 27.76 | 2677 | 3105 | 0.8620 | 0.9568 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 39.41 | 27.76 | 939 | 3105 | 0.3024 | 0.6777 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 39.41 | 27.76 | 3157 | 3105 | 1.0165 | 1.0048 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 41.11 | 27.76 | 2833 | 3331 | 0.8504 | 0.9536 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 41.11 | 27.76 | 2866 | 3331 | 0.8603 | 0.9569 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 41.11 | 27.76 | 1075 | 3331 | 0.3227 | 0.6979 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 41.11 | 27.76 | 3324 | 3331 | 0.9978 | 0.9994 | MN20160318_Q01 | M13 |